Review: taking Clarithromycin and Sporanox together


Summary

Drug interactions are reported among people who take Clarithromycin and Sporanox together. This review analyzes the effectiveness and drug interactions between Clarithromycin and Sporanox. It is created by eHealthMe based on reports of 260 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Clarithromycin

Clarithromycin has active ingredients of clarithromycin. It is often used in helicobacter infection. (latest outcomes from Clarithromycin 18,543 users)

Sporanox

Sporanox has active ingredients of itraconazole. It is often used in fungal nail infection. (latest outcomes from Sporanox 4,764 users)

On Sep, 26, 2016

260 people who take Clarithromycin, Sporanox are studied.


Number of reports submitted per year:

Clarithromycin and Sporanox drug interactions.

Drug effectiveness over time:

Clarithromycin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Sporanox:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Clarithromycin:
  • female: 0.0% - (0 of 0 people)
  • male: 50.0% - (1 of 2 people)
Sporanox:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Clarithromycin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 50.0% - (1 of 2 people)
Sporanox:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • haemolytic anaemia
  • idiopathic thrombocytopenic purpura
  • cerebral haemorrhage
  • tachycardia
  • pyrexia
  • acute graft versus host disease
  • liver disorder
  • acute graft versus host disease in skin
  • acute respiratory distress syndrome
  • anaemia
1 - 6 months:
  • gamma-glutamyltransferase increased
  • white blood cell count decreased
  • asthenia
  • blood alkaline phosphatase increased
  • bone marrow failure
  • cytomegalovirus viraemia
  • febrile neutropenia
  • hypotension
  • meningitis
  • neoplasm malignant
6 - 12 months:
  • acute graft versus host disease
  • cerebral haemorrhage
  • haemolytic anaemia
  • idiopathic thrombocytopenic purpura
  • swelling
  • anaemia
  • aplastic anaemia
  • asthma
  • bronchopneumonia
  • cardiac failure congestive
1 - 2 years:
  • pneumocystis jiroveci pneumonia
  • renal tubular acidosis
  • bronchopulmonary aspergillosis allergic
  • eosinophilic pneumonia
  • pulmonary granuloma
2 - 5 years:
  • aspergilloma
  • colitis
  • diarrhoea
  • hepatic function abnormal
  • lung infiltration
  • pulmonary cavitation
  • weight decreased
not specified:
  • pyrexia
  • white blood cell count decreased
  • dyspnoea
  • renal impairment
  • weight decreased
  • blood creatinine increased
  • pleural effusion
  • chest pain
  • platelet count decreased
  • depressed level of consciousness

Most common drug interactions by gender *:

female:
  • tachycardia
  • pleural effusion
  • pyrexia
  • white blood cell count decreased
  • convulsion
  • renal impairment
  • asthma
  • c-reactive protein increased
  • gastric cancer
  • nausea
male:
  • pyrexia
  • white blood cell count decreased
  • dyspnoea
  • blood creatinine increased
  • haemolytic anaemia
  • idiopathic thrombocytopenic purpura
  • platelet count decreased
  • weight decreased
  • cerebral haemorrhage
  • liver disorder

Most common drug interactions by age *:

0-1:
  • abdominal pain
  • clostridial infection
  • conjunctivitis
  • diarrhoea
  • disseminated intravascular coagulation
  • febrile neutropenia
  • hepatic function abnormal
  • neutrophil count decreased
  • pain
  • penile ulceration
2-9:
  • haemolytic anaemia
  • idiopathic thrombocytopenic purpura
  • cerebral haemorrhage
  • acute graft versus host disease
  • acute graft versus host disease in skin
  • acute respiratory distress syndrome
  • cytomegalovirus test positive
  • post transplant lymphoproliferative disorder
  • aspergilloma
  • respiratory distress
10-19:
  • tachycardia
  • hypokalaemia
  • muscular weakness
  • alopecia
  • sinusitis
  • blood creatine phosphokinase increased
  • c-reactive protein increased
  • myelocyte percentage increased
  • alanine aminotransferase increased
  • anorexia
20-29:
  • convulsion
  • white blood cell count decreased
  • chylothorax
  • cytomegalovirus viraemia
  • enterocolitis
  • hyperglycaemia
  • lymphatic duct rupture
  • pleural effusion
  • pneumonia staphylococcal
  • pneumothorax
30-39:
  • pyrexia
  • pneumonia
  • cd4 lymphocytes decreased
  • cough
  • headache
  • lymphadenopathy
  • muscle rigidity
  • peptic ulcer haemorrhage
  • agitation
  • anaemia
40-49:
  • pyrexia
  • dyspnoea
  • neutropenia
  • respiratory failure
  • drug ineffective
  • dyspnoea exertional
  • fall
  • productive cough
  • syncope
  • metabolic acidosis
50-59:
  • dyspnoea
  • chest pain
  • coronary artery disease
  • dyspepsia
  • hypertension
  • myocardial infarction
  • upper respiratory tract infection
  • hepatic function abnormal
  • pulmonary granuloma
  • actinic keratosis
60+:
  • white blood cell count decreased
  • platelet count decreased
  • pyrexia
  • weight decreased
  • blood creatinine increased
  • lung infiltration
  • pulmonary cavitation
  • liver disorder
  • uveitis
  • aspergilloma

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Clarithromycin and Sporanox?

Can you answer these questions?

More questions for: Clarithromycin, Sporanox

You may be interested in these reviews

More reviews for: Clarithromycin, Sporanox

On eHealthMe, Clarithromycin (clarithromycin) is often used to treat helicobacter infection. Sporanox (itraconazole) is often used to treat fungal nail infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.